Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? - Wikidata - wikimedia - TriplyDB

Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

http://www.wikidata.org/entity/Q35240062

about

Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease Umbilical cord-derived mesenchymal stromal cells: predictive obstetric factors for cell proliferation and chondrogenic differentiation.Clinical mesenchymal stromal cell products undergo functional changes in response to freezing.The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice.Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.Mesenchymal stem cells provide prophylaxis against acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: A meta-analysis of animal models Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions.Biobanking of Human Mesenchymal Stem Cells: Future Strategy to Facilitate Clinical Applications.Clumping and Viability of Bone Marrow Derived Mesenchymal Stromal Cells under Different Preparation Procedures: A Flow Cytometry-Based In Vitro Study Spinal cord injuries: how could cell therapy help?In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter.Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process Indoleamine 2,3-Dioxygenase Is Dispensable for The Immunomodulatory Function of Stem Cells from Human Exfoliated Deciduous Teeth.Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid.Combinations of Osmolytes, Including Monosaccharides, Disaccharides, and Sugar Alcohols Act in Concert During Cryopreservation to Improve Mesenchymal Stromal Cell Survival.Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs).Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus.An engineered biomarker system to monitor and modulate immune clearance of cell therapies.Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock?Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cells.Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon-γ Prelicensing is Context Dependent.Stem cell therapy in multiple sclerosis: a future perspective.Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.

P2860

Q26771451-B3DFBB36-407D-4857-8444-98C3B97D5638 Q26776414-BE75EEAF-08D5-48E9-89A3-9EA08A4EB4AA Q26800181-93D8C6B0-0EAD-40D4-84EE-6335254E0F0A Q28071916-48A69FB2-4D50-438E-AE75-DF55797E1A66 Q28077427-974EB68A-6D65-4554-8C68-83EB2C9F92E4 Q28079823-C5A48A92-EB8E-4543-B99B-01CB07286A72 Q28081921-AEE0D21A-6665-4CB1-B3B5-A4E4DE192A1C Q33872100-3E0DB708-2130-4CFC-B988-6B0CF778BF4B Q34759028-63090A2B-BC7F-4E1E-9948-0B57857A0641 Q35206489-BACDD005-ADF8-482F-B8B7-327522FA3EE4 Q35665325-7A5C9C20-5271-41E3-8459-A446A5D5EBFD Q35930081-3D5EEB30-628F-46F5-95D3-F2DA3F77978F Q36925541-1BD72DCA-7D29-4ABF-B3E0-56B60EE2E795 Q36939755-AC9EC9C6-6222-4BA5-A923-3A30E78A1B51 Q37000249-6660E94E-BCAD-4013-88AE-ADC0587E87EF Q37641684-69FEF84D-7EF8-4D8F-A7E1-6FDF8BDEAB43 Q37671213-E0097354-B510-4392-9018-268B279E0942 Q37692502-3ED76B67-AB0E-402F-9255-BB6ACF062624 Q38730028-4BCAC230-68C2-4684-AE77-A04B2CA35E39 Q38734508-1BAE61D5-CC7C-45E1-ABA9-E41B7CDF9AE5 Q38796118-DCFE1B0C-4FA2-4113-88AA-362AD1ECBB26 Q38796125-D2ED08DE-A470-4C60-A182-76304755EE10 Q38955586-73756DE7-A58E-4112-BB86-35E56EE3CB60 Q39183871-4199EBFC-8A5D-43A7-B263-4B200E718B3A Q39597655-FB255878-B277-4B97-833D-1D4121A347E5 Q39787750-4567F1E2-B345-4B99-BB23-5E66E933BCBA Q40756307-07BC4D87-9E9A-4D5D-BA1A-BFB51B628969 Q41046577-CD883E69-CC87-49AD-AC4C-CEE75C555E9C Q41132806-3029ED31-7B8A-45A0-B514-B0A3DDCB781F Q41618398-62111DBD-4ACF-4C9A-875B-F2093BD5E4B3 Q42152726-248972AD-BB87-40A7-8D3F-41AFD4ACE913 Q42774266-DC7301E4-BAAD-407D-846B-CBAA6815975D Q47098959-45A59129-EC3C-4D54-AF22-8EDC00196D2B Q47155691-22A3D89D-1817-42B6-8021-AA5C573F1BC7 Q47667916-8DBEA4A0-12BC-4F29-B3AF-BB7E10827A95 Q48150912-CDB573C2-9E93-4A8B-84AE-1F36FE82BF11 Q48265135-8146D5B3-18D9-436A-8F6A-C6813F548752 Q48290478-42033F8B-0990-45FC-9046-2B805F1531F2 Q48450832-96468F5C-DCE1-43EF-A281-230F32137000 Q49961729-59B43EE9-5BC3-4F0A-9EED-35370B7A5A9E

P2860

Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

http://www.wikidata.org/entity/Q35240062

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Do cryopreserved mesenchymal s ...... ry and therapeutic properties?

@ast

Do cryopreserved mesenchymal s ...... ry and therapeutic properties?

@en

type

label

Do cryopreserved mesenchymal s ...... ry and therapeutic properties?

@ast

Do cryopreserved mesenchymal s ...... ry and therapeutic properties?

@en

prefLabel

Do cryopreserved mesenchymal s ...... ry and therapeutic properties?

@ast

Do cryopreserved mesenchymal s ...... ry and therapeutic properties?

@en

P1433

Q35240062-B17EF988-F212-4318-86E8-B3A594BCA402

P1476

Q35240062-3DD399E6-21A1-4425-A711-5394A4272577

P2093

Q35240062-5CC4A0E1-E7CE-4C86-979C-F4C9664EF3E4

Q35240062-5E120DEF-C044-4B62-8013-194D61B29B25

Q35240062-7190451D-5E8D-4DB5-B753-1C1A69F3B0B4

Q35240062-81FE0A5F-D3C0-49C8-9E8D-840136590E54

Q35240062-87FB62FF-4B25-459D-9D79-745134074EC1

Q35240062-9AB9E7AB-E3B0-461E-AAE6-BDAFC0F6E71C

Q35240062-9C09ABD1-18B6-4E6F-A792-28389704F02C

Q35240062-B30B7A2E-203D-4B8B-9391-DCBD4AFB6142

Q35240062-D5C1EAB2-7740-433B-AACE-666D5D780811

Q35240062-DA33CA33-0F67-4D51-B1A1-4C5E31D1300E

P2860

Q35240062-0A18C14B-1535-4671-BF17-5E3050FEDCF6

Q35240062-0B561B04-1254-4665-BE8D-4E6BF5CEC94C

Q35240062-1395D25E-A043-4D03-88CC-39025B941D2F

Q35240062-14D027B4-6964-44DF-8702-9346F3FE9828

Q35240062-17BB1866-7902-4193-B7EB-D2D11F938356

Q35240062-18D1D695-1B2A-4D39-B14E-8C08A0CBDD7B

Q35240062-221CFED5-0319-4B9C-893C-4FAA579C571C

Q35240062-24FB338F-4A85-4489-A13C-36E18967941F

Q35240062-2F6D7BA5-8D23-4A2C-B8AC-C1850D6F9653

Q35240062-35965D70-C68B-4C25-B1F6-A525CF0F2DBD

P304

Q35240062-EBEBB802-56F9-4FAC-9834-7A16356CAC12

P31

Q35240062-85BBD8FD-3285-43A7-9B0B-54B8574EBF0D

P356

Q35240062-2BDBD1D8-2DC2-474A-94A2-BD54D32EC667

P433

Q35240062-2B409A31-3614-43A2-882D-1841DA0A478E

P478

Q35240062-FB3AF067-5BA0-4F9C-80E9-FBF33B77943A

P50

Q35240062-7DE76C4C-15EE-4B0C-9F74-1D9BFA334083

Q35240062-E0D45210-BB04-424F-B72D-64189D602544

Q35240062-E743BA4D-B5AC-4DEE-B2F9-AC4C20F06681

Q35240062-F0E7E3F2-D658-4A1E-8083-EF0A3AD7C2F2

P577

Q35240062-3520842C-AF43-48D3-975B-758FDE39E777

P5875

Q35240062-026EF4E0-53B7-4AEC-8868-CA34A7343A81

P698

Q35240062-E1C0259D-1813-4724-AEDC-C2756FE7CE31

P921

Q35240062-50360D68-AA18-458C-B236-E19231BB596A

P932

Q35240062-4F4DDF05-4962-49F3-8BDF-1D9DFC88C5C9

P356

P1433

P1476

Do cryopreserved mesenchymal s ...... ry and therapeutic properties?

@en

P2093

Helena Lönnies

http://www.w3.org/2001/XMLSchema#string

Jessica J Alm

http://www.w3.org/2001/XMLSchema#string

Katarina Le Blanc

http://www.w3.org/2001/XMLSchema#string

Kristina Nilsson-Ekdahl

http://www.w3.org/2001/XMLSchema#string

Lech Ignatowicz

http://www.w3.org/2001/XMLSchema#string

Lena von Bahr

http://www.w3.org/2001/XMLSchema#string

Lillemor Stenbeck-Funke

http://www.w3.org/2001/XMLSchema#string

Matthew Locke

http://www.w3.org/2001/XMLSchema#string

Nina Heldring

http://www.w3.org/2001/XMLSchema#string

Osama A Hamad

http://www.w3.org/2001/XMLSchema#string

P2860

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

Mesenchymal stem cells: immune evasive, not immune privileged

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

Complement: a key system for immune surveillance and homeostasis

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?

Immunogenic and tolerogenic cell death.

Mesenchymal stem cell therapy: Two steps forward, one step back

An appetite for apoptotic cells? Controversies and challenges.

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses

P304

2430-2442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.1729

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

John D. Lambris

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262150948

http://www.w3.org/2001/XMLSchema#string

P698

24805247

http://www.w3.org/2001/XMLSchema#string

P921

cryopreservation

P932

4381870

http://www.w3.org/2001/XMLSchema#string